Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of Myod1 monoclonal antibody, clone 5.8A
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Cat,Human,Mouse,Rat |
| Host species | Mouse |
| Applications | IP,IHC-Fr,ICC,WB-Ce,IF |
More info about Myod1 monoclonal antibody, clone 5.8A
| Brand: | Abnova |
| Reference: | MAB0077 |
| Product name: | Myod1 monoclonal antibody, clone 5.8A |
| Product description: | Mouse monoclonal antibody raised against partial recombinant Myod1. |
| Clone: | 5.8A |
| Isotype: | IgG |
| Gene id: | 17927 |
| Gene name: | Myod1 |
| Gene alias: | AI503393|MYF3|MyoD|Myod-1 |
| Gene description: | myogenic differentiation 1 |
| Immunogen: | Recombinant protein corresponding to amino acids 180-189 of mouse Myod1. |
| Form: | Liquid |
| Recommend dilutions: | The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.05% BSA, 0.05% sodium azide) |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Mouse |
| Antigen species / target species: | Mouse |
| Reactivity: | Cat,Human,Mouse,Rat |
| Application image: |  |
| Application image note: | Immunohistochemistry (Frozen sections) using Myod1 monoclonal antibody, clone 5.8A (Cat # MAB0077) monoclonal antibody. A. Rhabdomyosaroma (nuclei are stained), B. Lymphoma (staining is absent) . |
| Applications: | IP,IHC-Fr,ICC,WB-Ce,IF |
| Shipping condition: | Dry Ice |
| Publications: | Skeletal muscle insulin resistance induced by adipocyte-conditioned medium: underlying mechanisms and reversibility.Sell H, Eckardt K, Taube A, Tews D, Gurgui M, Van Echten-Deckert G, Eckel J. Am J Physiol Endocrinol Metab. 2008 Jun;294(6):E1070-7. Epub 2008 Mar 25. |